1
|
Ayama-Canden S, Tondo R, Pineros Leyton ML, Ninane N, Demazy C, Dieu M, Fattaccioli A, Sauvage A, Tabarrant T, Lucas S, Bonifazi D, Michiels C. Indacaterol inhibits collective cell migration and IGDQ-mediated single cell migration in metastatic breast cancer MDA-MB-231 cells. Cell Commun Signal 2023; 21:301. [PMID: 37904233 PMCID: PMC10614342 DOI: 10.1186/s12964-023-01340-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2023] [Accepted: 09/27/2023] [Indexed: 11/01/2023] Open
Abstract
Metastasis is the main cause of deaths related to breast cancer. This is particular the case for triple negative breast cancer. No targeted therapies are reported as efficient until now. The extracellular matrix, in particular the fibronectin type I motif IGDQ, plays a major role in regulating cell migration prior metastasis formation. This motif interacts with specific integrins inducing their activation and the migratory signal transduction.Here, we characterized the migratory phenotype of MDA-MB-231 cells, using functionalized IGDQ-exposing surfaces, and compared it to integrin A5 and integrin B3 knock-down cells. A multiomic analysis was developed that highlighted the splicing factor SRSF6 as a putative master regulator of cell migration and of integrin intracellular trafficking. Indacaterol-induced inhibition of SRSF6 provoked: i) the inhibition of collective and IGDQ-mediated cell migration and ii) ITGA5 sequestration into endosomes and lysosomes. Upon further studies, indacaterol may be a potential therapy to prevent cell migration and reduce metastasis formation in breast cancer. Video Abstract.
Collapse
Affiliation(s)
- Sophie Ayama-Canden
- URBC - NARILIS, University of Namur, Rue de Bruxelles 61, 5000, Namur, Belgium
| | - Rodolfo Tondo
- Cardiff University, Park Place, Main Building, Wales, CF10 3AT, UK
| | | | - Noëlle Ninane
- URBC - NARILIS, University of Namur, Rue de Bruxelles 61, 5000, Namur, Belgium
| | - Catherine Demazy
- URBC - NARILIS, University of Namur, Rue de Bruxelles 61, 5000, Namur, Belgium
- MaSUN, Mass Spectrometry Facility, University of Namur, 61, Rue de Bruxelles, 5000, Namur, Belgium
| | - Marc Dieu
- MaSUN, Mass Spectrometry Facility, University of Namur, 61, Rue de Bruxelles, 5000, Namur, Belgium
| | - Antoine Fattaccioli
- URBC - NARILIS, University of Namur, Rue de Bruxelles 61, 5000, Namur, Belgium
| | - Aude Sauvage
- URBC - NARILIS, University of Namur, Rue de Bruxelles 61, 5000, Namur, Belgium
| | - Tijani Tabarrant
- LARN - NARILIS, University of Namur, Rue de Bruxelles 61, Namur, 5000, Belgium
| | - Stéphane Lucas
- LARN - NARILIS, University of Namur, Rue de Bruxelles 61, Namur, 5000, Belgium
| | - Davide Bonifazi
- Cardiff University, Park Place, Main Building, Wales, CF10 3AT, UK
- Institute of Organic Chemistry, University of Vienna, Währinger Str. 38, 1090, Vienna, Austria
| | - Carine Michiels
- URBC - NARILIS, University of Namur, Rue de Bruxelles 61, 5000, Namur, Belgium.
| |
Collapse
|
2
|
Evidence for continuity of interstitial spaces across tissue and organ boundaries in humans. Commun Biol 2021; 4:436. [PMID: 33790388 PMCID: PMC8012658 DOI: 10.1038/s42003-021-01962-0] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2020] [Accepted: 03/02/2021] [Indexed: 12/19/2022] Open
Abstract
Bodies have continuous reticular networks, comprising collagens, elastin, glycosaminoglycans, and other extracellular matrix components, through all tissues and organs. Fibrous coverings of nerves and blood vessels create structural continuity beyond organ boundaries. We recently validated fluid flow through human fibrous tissues, though whether these interstitial spaces are continuous through the body or discontinuous, confined within individual organs, remains unclear. Here we show evidence for continuity of interstitial spaces using two approaches. Non-biological particles (tattoo pigment, colloidal silver) were tracked within colon and skin interstitial spaces and into adjacent fascia. Hyaluronic acid, a macromolecular component of interstitial spaces, was also visualized. Both techniques demonstrate interstitial continuity within and between organs including within perineurium and vascular adventitia traversing organs and the spaces between them. We suggest that there is a body-wide network of fluid-filled interstitial spaces that has significant implications for molecular signaling, cell trafficking, and the spread of malignant and infectious disease.
Collapse
|
3
|
J J, Vanisree AJ. Naringenin Sensitizes Resistant C6 Glioma Cells with a Repressive Impact on the Migrating Ability. Ann Neurosci 2020; 27:114-123. [PMID: 34556949 PMCID: PMC8455008 DOI: 10.1177/0972753120950057] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
Background: Glioma, the most common form of a malignant brain tumour is characterised by a poor prognosis, which is attributable to its resistance against current therapeutic approaches. Temozolomide (TMZ), a DNA alkylating agent, is the first-line drug for glioma treatment. Long-term treatment using TMZ was reported to culminate in the development of resistance with overexpression of multidrug resistance 1 gene coded protein P-glycoprotein, which in turn releases the drugs from the tumour cells. Purpose: Thus, to circumvent such resistance issues, the current study attempted to explore the effect of naringenin (a flavanone) with proven antiglial tumour potential, in mitigating the features of TMZ resistance. Methods: Colony-forming assay, invasion assay and scratch wound assay were performed among the groups, namely tumour control (C6), vehicle control (V), naringenin (NGEN)-treated, drug-resistant tumour cells (C6R), and drug resistance cells added with NGEN (C6R+NGEN), to examine the impact of NGEN on migration and invasion. The effect of NGEN on filopodia length and density during cell migration was also studied in addition to the matrix metalloproteinases (MMP-2 and MMP-9) and p-ERK levels. Results and Conclusion: NGEN and C6R+NGEN groups had shown significant reduction (P < .01) in length and density of filopodia, colony formation, invasion and wound healing. Further, NGEN could also modify the assessed protein levels (P < .001), which were involved in migration and invasion in sensitive and resistant cells. Our study had provided the first evidence on NGEN-induced enhanced sensitivity against TMZ resistance with profound influence as an antimigratory and anti-invasive agent.
Collapse
Affiliation(s)
- Jayalakshmi J
- Department of Biochemistry, University of Madras, Chennai, Tamil Nadu, India
| | | |
Collapse
|
4
|
Gerashchenko T, Zavyalova M, Denisov E, Krakhmal N, Pautova D, Litviakov N, Vtorushin S, Cherdyntseva N, Perelmuter V. Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity. Acta Naturae 2017; 9:56-67. [PMID: 28461975 PMCID: PMC5406661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2016] [Indexed: 11/05/2022] Open
Abstract
Breast cancer (BC) demonstrates considerable intratumoral morphological heterogeneity. The aim of this work was to evaluate the relationship among different morphological structures, the rate of metastasis, and efficacy of neoadjuvant chemotherapy (NAC) in NAC-treated (n = 427) and NAC-naïve (n = 249) BC patients. We also studied the involvement of an epithelial-mesenchymal transition (EMT) in the development of the intratumoral morphological heterogeneity of BC. We found a significant association between the intratumoral morphological heterogeneity and the rate of BC metastasis and response to NAC, which, in most cases, correlated with the presence of alveolar and trabecular structures. In particular, the rate of lymph node metastasis in tumors containing alveolar and trabecular structures was higher compared to that in tumors lacking such structures. NAC-treated patients with alveolar and trabecular structures had a high distant metastasis rate and a low metastasis-free survival rate. Furthermore, alveolar and trabecular structures were found to be associated with a lack of response to NAC. Interestingly, the association between alveolar structures and a high distant metastasis rate was found only in NAC-unresponsive patients, whereas the association between trabecular structures and an increased distant metastasis was revealed in responders. Alveolar structures were associated with chemoresistance only in patients with lymph node metastases, whereas trabecular structures were associated with chemoresistance only in patients without lymph node metastases. In general, increased intratumoral morphological diversity correlated with considerable chemoresistance and a high metastasis rate of BC. We found variable expressions of epithelial (EPCAM and CDH1) and mesenchymal (ITGA5, ITGB5, CDH2, CDH11, TGFb2, ZEB1, MMP2, DCN, MST1R) markers and, thus, different EMT manifestations in different morphological structures. Therefore, intratumoral morphological heterogeneity of BC may serve as an indicator of the metastatic potential and tumor chemosensitivity.
Collapse
Affiliation(s)
- T.S. Gerashchenko
- Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kooperativny per., 634050, Tomsk, Russia
- Tomsk State University, 36 Lenin Ave., Tomsk, 634050, Russia
| | - M.V. Zavyalova
- Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kooperativny per., 634050, Tomsk, Russia
- Tomsk State University, 36 Lenin Ave., Tomsk, 634050, Russia
- Siberian State Medical University, Moskovsky trakt 2, Tomsk, 634050, Russia
| | - E.V. Denisov
- Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kooperativny per., 634050, Tomsk, Russia
- Tomsk State University, 36 Lenin Ave., Tomsk, 634050, Russia
| | - N.V. Krakhmal
- Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kooperativny per., 634050, Tomsk, Russia
- Siberian State Medical University, Moskovsky trakt 2, Tomsk, 634050, Russia
| | - D.N. Pautova
- Tomsk State University, 36 Lenin Ave., Tomsk, 634050, Russia
| | - N.V. Litviakov
- Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kooperativny per., 634050, Tomsk, Russia
- Tomsk State University, 36 Lenin Ave., Tomsk, 634050, Russia
| | - S.V. Vtorushin
- Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kooperativny per., 634050, Tomsk, Russia
- Siberian State Medical University, Moskovsky trakt 2, Tomsk, 634050, Russia
| | - N.V. Cherdyntseva
- Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kooperativny per., 634050, Tomsk, Russia
- Tomsk State University, 36 Lenin Ave., Tomsk, 634050, Russia
| | - V.M. Perelmuter
- Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kooperativny per., 634050, Tomsk, Russia
- Siberian State Medical University, Moskovsky trakt 2, Tomsk, 634050, Russia
| |
Collapse
|
5
|
Kuźnar-Kamińska B, Mikuła-Pietrasik J, Sosińska P, Książek K, Batura-Gabryel H. COPD promotes migration of A549 lung cancer cells: the role of chemokine CCL21. Int J Chron Obstruct Pulmon Dis 2016; 11:1061-6. [PMID: 27307721 PMCID: PMC4888725 DOI: 10.2147/copd.s96490] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
Patients with COPD develop lung cancer more frequently than healthy smokers. At the same time, molecular mediators promoting various aspects of cancer cell progression are still elusive. In this report, we examined whether COPD can be coupled with increased migration of non-small-cell lung cancer cells A549 and, if so, whether this effect may be related to altered production and activity of chemokines CCL21, CXCL5, and CXCL12. The study showed that the migration of A549 cells through the polycarbonate membrane and basement membrane extract toward a chemotactic gradient elicited by serum from patients with COPD was markedly higher as compared with serum from healthy donors. The concentration of CCL21 and CXCL12, but not CXCL5, in serum from patients with COPD was also increased. Experiments in which CCL21- and CXCL12-dependent signaling was blocked revealed that increased migration of the cancer cells upon treatment with serum from patients with COPD was mediated exclusively by CCL21. Collectively, our results indicate that COPD may contribute to the progression of lung cancer via CCL21-dependent intensification of cancer cell migration.
Collapse
Affiliation(s)
| | | | - Patrycja Sosińska
- Department of Pathophysiology, Poznań University of Medical Sciences, Poznań, Poland
| | - Krzysztof Książek
- Department of Pathophysiology, Poznań University of Medical Sciences, Poznań, Poland
| | | |
Collapse
|
6
|
Krakhmal NV, Zavyalova MV, Denisov EV, Vtorushin SV, Perelmuter VM. Cancer Invasion: Patterns and Mechanisms. Acta Naturae 2015; 7:17-28. [PMID: 26085941 PMCID: PMC4463409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
Cancer invasion and the ability of malignant tumor cells for directed migration and metastasis have remained a focus of research for many years. Numerous studies have confirmed the existence of two main patterns of cancer cell invasion: collective cell migration and individual cell migration, by which tumor cells overcome barriers of the extracellular matrix and spread into surrounding tissues. Each pattern of cell migration displays specific morphological features and the biochemical/molecular genetic mechanisms underlying cell migration. Two types of migrating tumor cells, mesenchymal (fibroblast-like) and amoeboid, are observed in each pattern of cancer cell invasion. This review describes the key differences between the variants of cancer cell migration, the role of epithelial-mesenchymal, collective-amoeboid, mesenchymal-amoeboid, and amoeboid- mesenchymal transitions, as well as the significance of different tumor factors and stromal molecules in tumor invasion. The data and facts collected are essential to the understanding of how the patterns of cancer cell invasion are related to cancer progression and therapy efficacy. Convincing evidence is provided that morphological manifestations of the invasion patterns are characterized by a variety of tissue (tumor) structures. The results of our own studies are presented to show the association of breast cancer progression with intratumoral morphological heterogeneity, which most likely reflects the types of cancer cell migration and results from different activities of cell adhesion molecules in tumor cells of distinct morphological structures.
Collapse
Affiliation(s)
- N. V. Krakhmal
- Siberian State Medical University, Moskovskiy Trakt, 2, 634050, Tomsk, Russia
| | - M. V. Zavyalova
- Siberian State Medical University, Moskovskiy Trakt, 2, 634050, Tomsk, Russia
- Tomsk Cancer Research Institute, Kooperativny Pereulok, 5, 634050, Tomsk, Russia
- Tomsk State University, Prosp. Lenina, 36, 634050, Tomsk, Russia
| | - E. V. Denisov
- Tomsk Cancer Research Institute, Kooperativny Pereulok, 5, 634050, Tomsk, Russia
- Tomsk State University, Prosp. Lenina, 36, 634050, Tomsk, Russia
| | - S. V. Vtorushin
- Siberian State Medical University, Moskovskiy Trakt, 2, 634050, Tomsk, Russia
- Tomsk Cancer Research Institute, Kooperativny Pereulok, 5, 634050, Tomsk, Russia
| | - V. M. Perelmuter
- Siberian State Medical University, Moskovskiy Trakt, 2, 634050, Tomsk, Russia
- Tomsk Cancer Research Institute, Kooperativny Pereulok, 5, 634050, Tomsk, Russia
| |
Collapse
|